Spots Global Cancer Trial Database for breast cancer recurrent
Every month we try and update this database with for breast cancer recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Registry of Local Recurrences After Breast-conserving Surgery | NCT05406661 | Breast Cancer R... | 18 Years - | Universidade do Porto | ||
| Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC | NCT05464082 | Breast Cancer R... | Functional Prec... | 18 Years - | University of Utah | |
| S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer | NCT02947061 | Breast Cancer R... | S1 plus Docetax... Capecitabine pl... | 18 Years - 75 Years | ChineseAMS | |
| EpCAM CAR-T for Treatment of Advanced Solid Tumors | NCT02915445 | Malignant Neopl... Breast Cancer R... Gastric Cancer ... | EpCAM CAR-T cel... | 18 Years - 65 Years | Sichuan University | |
| Prolonged Nightly Fasting in Breast Cancer Survivors | NCT04330339 | Fasting Breast Cancer Survivorship Breast Cancer R... | Fasting | 18 Years - | Massachusetts General Hospital | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer | NCT02844335 | Breast Cancer R... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Registry of Local Recurrences After Breast-conserving Surgery | NCT05406661 | Breast Cancer R... | 18 Years - | Universidade do Porto | ||
| Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. | NCT05301530 | Breast Cancer M... Breast Cancer F... Breast Cancer R... | Faceptor Herceptin Docetaxel | 18 Years - 65 Years | Nanogen Pharmaceutical Biotechnology Joint Stock Company | |
| Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) | NCT05592938 | Breast Cancer Breast Cancer R... | rPBI | 18 Years - 99 Years | University Health Network, Toronto | |
| S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer | NCT02947061 | Breast Cancer R... | S1 plus Docetax... Capecitabine pl... | 18 Years - 75 Years | ChineseAMS | |
| Prolonged Nightly Fasting in Breast Cancer Survivors | NCT04330339 | Fasting Breast Cancer Survivorship Breast Cancer R... | Fasting | 18 Years - | Massachusetts General Hospital | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer | NCT02844335 | Breast Cancer R... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) | NCT05592938 | Breast Cancer Breast Cancer R... | rPBI | 18 Years - 99 Years | University Health Network, Toronto | |
| Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) | NCT05592938 | Breast Cancer Breast Cancer R... | rPBI | 18 Years - 99 Years | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
